Interview With A Renal Medullary Carcinoma Survivor

Video Description

@chubbyemu video: https://www.youtube.com/watch?v=3E75UvmY9GA A Brief Discussion On Renal Medullary Carcinoma: https://youtu.be/j7WGP6sJBLk Audio version of this video: https://anchor.fm/chubbyemu/episodes/Interview-With-A-Rare-Renal-Medullary-Carcinoma-Survivor-e167o99 Sickle Cell means Sickle Hemoglobinopathy, including Sickle Cell Disease, Sickle Cell Trait, Beta Thalassemia, Sickle Cell Hemoglobin-C Contact Cora: https://www.twitter.com/RMCAwareness Cora Facebook: https://www.facebook.com/RMCSupport A Man Felt Pain In His Back. This Is What Happened To His Kidneys. IG me: https://www.instagram.com/hemereview Tweet me: https://www.twitter.com/hemereview Thank you Dr Nizar Tannir, Dr Pavlos Msaouel, Cora and Herman Connor, and Dr Loren Stagg Production Assistant: Nick Brown Renal Medullary Carcinoma is a sickle cell related kidney malignancy that is usually diagnosed in young patients (median age at diagnosis 28 years old). It is considered a rare malignancy but likely afflicts more people than prior literature suggests given that review of that literature shows patients more in line with Renal Medullary Carcinoma rather than Collecting Duct Carcinoma. 3 year overall survival of RMC is 3%. Upfront chemotherapy then surgery is the suggested treatment. Response rate to platinum based chemotherapies, gemcitabine, doxorubicin is 29%.